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Case Report
INTRODUCTION
Multiple primary tumors (MPT) are rare and have different clinical 
presentations. Historically, Warren and Gates defined MPT as tumors 
that are histologically confirmed as malignant, separated by at least 
2 cm of normal mucosa, and/or chronologically separated by at least 
5 years, excluding metastatic tumors. When tumors develop simul-
taneously or within 6 months after discovery of the primary tumor, 
they are considered to be synchronous tumors. If this period exceeds 
6 months, they are defined as metachronous tumors(1). The most 
common findings are related to the presence of 2 tumors, and the 
gastrointestinal tract, breast, and skin are the most commonly invol-
ved primary sites. In the scientific literature, there are few descriptions 
of lymphoma as one of the primary types of MPT, and an association 
with the mantle cell lymphoma subtype is even more infrequent and 
results in a worse prognosis(1,2).
The term mantle cell lymphoma was first used in 1993 to describe 
the specific subtype of non-Hodgkin B-cell lymphoma with specific 
clinical and histopathological characteristics(3). It accounts for 3%-7% 
of all non-Hodgkin lymphomas and 1%-9% of all lymphomas in the 
periocular region(3-5). This disease primarily affects men aged over 60 
years and is usually a widespread and aggressive tumor(3,4). Because 
of its rarity, most of the descriptions in the literature are case reports, 
with some cases described in a large case series of lymphoma(4,6).
Here we present an atypical case of metachronous MPT associa-
ted with basal cell carcinoma of the skin, intestinal adenocarcinoma 
with regional lymph node metastasis, and non-Hodgkin B-cell mantle 
cell lymphoma of the bilateral orbits with systemic findings. 
CASE REPORT
A 73-year-old man who was retired and born and raised in São 
Bernardo do Campo, São Paulo, presented with a complaint of bilate-
ral eyelid edema with low visual acuity since 1 year and 6 months. The 
symptoms had first appeared on the left and progressed to the right. 
His family history included a brother who died of an abdominal tumor 
(exact type unknown). His ophthalmological history included bilate-
ral cataract surgery performed 5 years back. His past medical history 
included non-Hodgkin B-cell small cell lymphoma diagnosed in the 
first semester of 2010 through pleural biopsy and cervical lymph 
node involvement (Figure 1A and 1B); basal cell carcinoma diagnosed 
in the second semester of 2010 through biopsy of the skin over the 
right and left scapular area, left forehead, and chin (Figure 1C and 1D); 
and intestinal adenocarcinoma diagnosed in January 2011 through 
histopathological analysis of a piece of intestine removed during 
emergency surgery (right hemicolectomy and bowel resection for 
perforated acute abdomen), with regional lymph node metastases 
(Figure 1 e and 1F). 
Ectoscopy revealed bilateral proptosis, bilateral bulging in the 
upper and lower eyelid regions, which was more prominent on the 
left, and the presence of a solid lesion that was adherent to the deep 
planes and painless after significant reduction of the palpebral fissure 
http://dx.doi.org/10.5935/0004-2749.20140014
Case report of a metachronous multiple tumor: Mantle cell lymphoma in the orbital 
region associated with epithelial malignancies at other sites
Tumor múltiplo metacrônico: linfoma do manto na região orbital associado a neoplasias malignas 
epiteliais em outros sítios - relato de caso
Juliana S. F. Medrado1, Mirtha raMírez dittrich1, Jacqueline M. SouSa1, luiz F. teixeira1, Paulo GóiS ManSo1
 Submitted for publication: August 27, 2013
 Accepted for publication: October 07, 2013
 Study carried out at Orbital Disorders Service, Department of Ophthalmology, Universidade Federal 
de São Paulo.
1 Orbital Disorders Service, Department of Ophthalmology, Universidade Federal de São Paulo, SP, 
Brazil.
 Funding: No specific financial support was available for this study.
 Disclosure of potential conflicts of interest: J.S.F. Medrado, None; M.R. Dittrich, None; J.M. Sousa, 
None; L.F. Teixeira, None; P.G. Manso, None.
 Correspondence address: Jacqueline M. Sousa. Rua Botucatu, 821 - São Paulo (SP) - 04023-062 - 
Brazil - E-mail: jacmsousa@gmail.com
ABSTRACT
Here we report the case of a 73-year-old man who was diagnosed with metachro-
nous, multiple primary tumors with non-Hodgkin B-cell mantle cell lymphoma 
involving the orbit on the basis of biopsy and immunohistochemistry in 2012. The 
patient had been diagnosed with non-Hodgkin small cell lymphoma and basal 
cell skin carcinoma in 2010 and intestinal adenocarcinoma with metastasis to the 
regional lymph nodes in 2011, thus representing a typical case of metachronous, 
multiple primary tumors. Mantle cell lymphoma is a rare disease and its prog-
nosis is quite poor, particularly when it is associated with other metachronous 
malignancies. Therefore, physicians should consider mantle cell lymphoma as a 
differential diagnosis for neoplasms of the orbit. 
Keywords: Lymphoma, mantle cell/diagnosis; Orbital neoplasms/diagnosis; Lym-
phoma, non-Hodgkin; Case report 
RESUMO
Relatamos um caso de linfoma não-Hodgkin de células B subtipo células do manto 
acometendo região orbital, com o diagnóstico confirmado pela biópsia e testes imuno- 
-histoquímicos em 2012. O paciente apresentava história de linfoma não-Hodgkin de 
pequenas células em 2010, carcinoma basocelular de pele no mesmo ano e adenocar-
cinoma intestinal com metástase para linfonodos regionais em 2011; caracterizando 
um caso de tumor primário múltiplo metacrônico. O linfoma de células do manto é 
uma doença rara, ainda mais quando associado a outras neoplasias metacrônicas, 
apresentando prognóstico bastante reservado. Dessa forma, deve estar entre os diag -
nósticos diferenciais de neoplasias da órbita. 
Descritores: Linfoma de células do manto/diagnóstico; Neoplasias orbitárias; Linfoma 
não Hodgkin; Relato de caso
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cretion with entropion of the lower eyelid on both sides. Intraocular 
pressure, fundoscopy, and ocular motility examinations were not 
performed because of technical difficulties. 
The patient underwent computed tomography and magnetic 
resonance imaging of the orbit (Figure 3). Incisional bilateral eyelid 
biopsy was performed in February 2013 (Figure 4). Hematoxylin-eosin 
staining revealed relatively homogeneous small cells with slight nu-
clear irregularity. Immunohistochemistry was positive for CD5, CD20, 
and cyclin D1. On the basis of these findings, a diagnosis of non-Hodgkin 
B-cell mantle cell lymphoma was made.
The patient was referred to the Oncology Sector at UNIFESP, where 
he began his treatment with 3 cycles of CHOP (cyclophosphamide, 
Figure 1. A and B) Biopsy of the involved thoracic lymph node reveals positivity for cyclin 
D1 with nuclear immunostaining. C and D) Biopsy of the skin over the scapular region 
reveals basal cell carcinoma with infiltration of the basal membrane. E) Biopsy of the 
bowel shows intestinal adenocarcinoma, moderately differentiated, with mitosis and 
increased cell nuclei. F) Biopsy of the abdominal lymph node capsule shows metastasis 
of the intestinal adenocarcinoma, with intestinal glands
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Figure 2. Ectoscopy findings. There is bilateral bulging in the upper and lower eyelid 
region, more prominently on the left, with mucoid secretion.
Figure 3. Magnetic resonance imaging of the orbit: The image shows bilateral eyelid 
thickening, which is more pronounced on the left, and a lesion involving the eyeball, 
which is hypointense relative to fat on a T1 image and hyperintense on a T2 image, with 
contrast enhancement (gadolinium).
Figure 4. Incisional eyelid biopsy: Hematoxylin-eosin staining shows a relatively homo-
geneous population of small cells with slight nuclear irregularity. Immunohistochemistry 
is positive for CD5, CD20, and cyclin D1.
(Figure 2). Uncorrected visual acuity was 20/50 in the right eye and 
20/25 in the left eye. Anterior biomicroscopy revealed mucoid se-
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doxorubicin, vincristine, and prednisone), 6 cycles of FCR (fludarabi-
ne, cyclophosphamide, and rituximab), and radiotherapy The patient 
is being followed-up by a multidisciplinary team. 
DISCUSSION
MPT affects approximately 1.3%-2.5% patients diagnosed with 
malignancy, and patients with ≥3 MPTs account for 0.16%-0.26% of 
this total(1,7). Although the lesions described in the literature primarily 
involved the gastrointestinal tract, breast, and skin (non-melanoma), 
other sites can also be affected. Pandurengan et al.(8) described a case 
of gastrointestinal stromal tumor associated with gastric lymphoma, 
while Troyanova et al.(9) described an increased risk of MPT in Bulga-
rian patients diagnosed with malignant non-melanoma of the skin, 
primarily affecting the head and neck, thyroid, lung, larynx, bladder, 
colon, melanoma, and non-Hodgkin lymphoma. Dasanu et al.(2) repor-
ted a case of pancreatic adenocarcinoma associated with mantle cell 
lymphoma; this was the only case we found in PubMed and Bireme 
describing MPT involving the specific subtype of mantle cell lym-
phoma, similar to the present case. Our first tentative diagnosis was 
based on the patient’s personal history and was orbital metastasis. In 
our patient, any of the malignancies could be the origin of metastasis, 
indicating the importance of biopsy for histological confirmation. 
Systemic lymphomas (nodal and extranodal) can spread to the 
ocular adnexa. When there is ocular involvement secondary to a 
systemic lymphoma, the uvea is almost exclusively the affected site 
(choroid, ciliary body, and iris)(5). However, ocular adnexal lymphomas 
have not been associated with intraocular lymphomas. They are ge-
nerally indolent, painless, and well tolerated and mold to the adjacent 
structures without bone destruction in imaging studies(5). Rasmussen 
et al.(4) related the most common symptoms of mantle cell lymphoma 
in the orbital and adnexal region: irritation, pain, and epiphora. They 
also referred to eyelid masses, conjunctival swelling, and proptosis as 
the most frequent signs. Our patient complained of bilateral eyelid 
swelling, low visual acuity, and an orbital mass. Because this was a 
specific subtype of lymphoma, we believed that the orbital tumor in 
our patient was a metastasis of non-Hodgkin B-cell small cell lympho-
ma of the cervical lymph nodes. A factor in favor of this hypothesis 
is the rarity of the presence of two primary malignant tumors in the 
orbit; however, we have to remember that the primary sites for or-
bital metastasis are the breasts, lungs, and prostate. Our patient also 
presented with intestinal adenocarcinoma, which can metastasize 
to the orbit; however, this type of involvement is very rare. In such 
cases, imaging findings have been related to osseous changes such 
as hypo- or hyperostosis primarily located intra- or extraconally and 
occasionally involving the extraocular muscles. These characteristics 
were not found in the case presented(10).
Mantle cell lymphoma is a distinct subtype of non-Hodgkin B-cell 
tumors that primarily affect elderly men, unlike the majority of pe-
riocular lymphomas, which are more common in older women(4,6). As 
observed in our case, approximately one- to two-thirds of patients 
report a previous diagnosis of systemic lymphoma at diagnosis; for 
the remaining third, the diagnosis is made  when the disease is alrea-
dy widespread. This characteristic also differentiates it from other 
orbital lymphomas(4). Approximately 32%-71% of these tumors are 
bilateral, and the eyelid, orbit, and conjunctiva are the most involved 
regions(3-5). The bone marrow is involved in 50%-70% cases at diag-
nosis(4). In most cases, there is involvement of more than one site in 
the orbital region or the ocular adnexa(4). The most frequent signs 
and symptoms are irritation, ptosis, eyelid edema or mass, proptosis, 
pain, and diplopia; other less common findings include a mass in 
the region of the lacrimal gland, chemosis, conjunctival hyperemia, 
ocular motility alteration, tearing, and malalignment of the eyeball(3,4). 
Only 50% patients have a survival rate of >5 years(3,4).
There are some characteristic immunohistochemical markers 
(CD5+, CD20+, bcl-2+, CD21+ dendritic form, CD43+, CD23-, CD10, 
CD11c-, and CD25-) and genetic patterns characterized by the trans-
location t(11;14)(q13,q32), which causes overexpression of the CCND1 
gene and the protein cyclin D1(3-5). However, some authors have 
described atypical cases that were immunohistochemically negative 
for CD5(3). Coupland et al. showed p16 expression in 2 patients.6 Histo-
logically, this lymphoma is characterized by small cells with irregular 
and hyperchromatic nuclei and scant cytoplasm(6).
The European Task Force on Lymphoma has defined 3 types of 
mantle cell lymphoma growth patterns: diffuse (most common), 
no dular, and marginal zone(3,4). Some studies have shown that the 
mar ginal zone pattern is related to better prognosis, while others have 
demonstrated that all patterns have a similar prognosis(3). In fact, the 
prognosis is usually poor, with poor response to treatment, bone 
marrow involvement, and short survival duration. The poor prognosis 
is associated with increased mitotic activity (>20 mitoses/10x field), 
blastic morphology, peripheral involvement (atypical cells in the 
pe ripheral blood), and increased p53 expression(3,5). A few years ago, 
it was considered an untreatable disease with only palliative care 
options available, but nowadays, several types of treatments are being 
studied. Recently, some studies showed a response to combined the-
rapy with multiple chemotherapy regimens and rituximab (anti-CD20) 
in patients with an early diagnosis; other researchers have seen good 
results with bone marrow transplantation(3,4).
In conclusion, mantle cell lymphoma is a rare disease, usually wi-
despread, and carries a poor prognosis. Physicians should consider this 
malignancy as a differential diagnosis for neoplasms of the orbit. Rapid 
and accurate diagnosis by clinical and immunohistochemical tests is 
essential before referral of the patient for systemic evaluation and treat-
ment. This case report described an extremely rare occurrence, and in 
our knowledge, it represents the first case described in the scientific 
literature on metachronous MPT with bilateral non-Hodgkin B-cell 
mantle cell lymphoma of the orbit in a Brazilian patient.
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